Volume 46, Issue 12 e14492
ORIGINAL ARTICLE

Systems pharmacology-based drug discovery and active mechanism of phlorotannins for type 2 diabetes mellitus by integrating network pharmacology and experimental evaluation

Jialiang Chen

Jialiang Chen

School of Food Science and Technology, Dalian Polytechnic University, Dalian, China

Search for more papers by this author
Ping Li

Ping Li

School of Food Science and Technology, Dalian Polytechnic University, Dalian, China

Search for more papers by this author
Shuhong Ye

Shuhong Ye

School of Food Science and Technology, Dalian Polytechnic University, Dalian, China

Search for more papers by this author
Wei Li

Wei Li

Korean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu, South Korea

Search for more papers by this author
Ming Li

Ming Li

College of Basic Medical Science, Dalian Medical University, Dalian, China

Search for more papers by this author
Yan Ding

Corresponding Author

Yan Ding

School of Food Science and Technology, Dalian Polytechnic University, Dalian, China

Correspondence

Yan Ding, School of Food Science and Technology, Dalian Polytechnic University, Dalian, Liaoning 116034, China.

Email: [email protected]

Search for more papers by this author
First published: 17 November 2022
Citations: 7

Abstract

Phlorotannins, polyphenolic compounds that exist only in brown algae, have an effect on T2DM. However, the structure of phlorotannins is complex and diverse, and the complex role of therapeutic targets and active compounds has not been revealed. In this study, the potential targets and pharmacological effects of phlorotannins in the treatment of T2DM were identified based on network pharmacology and enzyme activity inhibition experiment. In total, 15 phlorotannins and 53 associated targets were yielded. Among them, SRC, ESR1, AKT1, HSP90AB1, and AR were defined as core targets. 527 GO biological processes items and 101 KEGG pathways were obtained, including EGFR tyrosine kinase inhibitor resistance, thyroid hormone signaling pathway, AGE-RAGE signaling pathway in diabetic complications, and VEGF signaling pathway. Phlorotannins could enable resistance against T2DM by inflammatory, survival, gene transcription, proliferation, apoptosis, and atherosclerosis. Finally, α-glucosidase inhibition assay and molecular docking proved the effect of selected phlorotannins on T2DM.

Practical applications

Phlorotannins are a kind of polyphenol compounds that only exists in brown algae. Its structure is polymerized by aromatic precursors phloroglucinol (1,3,5-trihydroxybenzene). They have aroused great interest due to their excellent and valuable biological activities. However, the structure of phlorotannins is complex and diverse, and the complex role of therapeutic targets and active compounds has not been revealed. In this study, the potential targets and pharmacological effects of phlorotannins in the treatment of T2DM were determined basis on network pharmacology and enzyme activity inhibition experiment. In conclusion, the results showed the value of phlorotannins treating on T2DM. Moreover, this study has great significance for improving the medicinal value of phlorotannins and screening natural products for the treatment of T2DM.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interest.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.